Role of gancyclovir and HAART administration in the treatment of a rare complication of HIV disease: Cytomegalovirus-associated Guillain-Barré syndrome

Journal of Chemotherapy

Volumn 13, Issue 5, 2001, Pages 575-577

  Calza, L ^a   Manfredi, R ^a   Marinacci, G ^a   Briganti, E ^a   Giuliani, R ^a   Talo, S ^a   Chiodo, F ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Cytomegalovirus; Gancyclovir; Guillain Barr syndrome; HAART; HIV infection

Indexed keywords

ANTIRETROVIRUS AGENT; GANCICLOVIR; LAMIVUDINE; NELFINAVIR; ZIDOVUDINE;

ADULT; ARTICLE; CASE REPORT; CYTOMEGALOVIRUS INFECTION; FACIAL NERVE PARALYSIS; GUILLAIN BARRE SYNDROME; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE;

EID: 0034782446     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2001.13.5.575     Document Type: Article

References (14)

1. Neuropathies in HIV infection
2. Guillain-Barré syndrome
3. Pathogenesis of Guillain-Barré syndrome
4. The spectrum of antecedent infections in Guillain-Barré syndrome. A case-control study
5. Campylobacter jejuni, Human Immunodeficiency Virus and the Guillain-Barré Syndrome
6. Guillain-Barré syndrome associated with human immunodeficiency virus infection in Zimbabwe
7. Assessment of current diagnostic criteria for Guillain-Barré Syndrome
8. Cytomegalovirus infections and anti-GM2 antibodies in Guillain-Barré syndrome
9. Antiganglioside antibodies in Guillain-Barré syndrome after a recent cytomegalovirus infection
10. Cross-reactive antibodies against GM2 and CMV-infected fibroblasts in Guillain-Barré syndrome
11. Human immunodeficiency virus and Guillain-Barré syndrome in intensive care unit patients
12. Cytomegalovirus infection and Guillain-Barré syndrome: The clinical, e]ectrophysiologic and prognostic features
13. Inflammatory demyelinating peripheral neuropathies associated with human T-cell lymphotropic virus type III infection
14. Neurological manifestations of cytomegalovirus infection in the acquired immunodeficiency syndrome